Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc

835. Gao CL, Dean RC, Pinto A, Mooneyhan
R, Connelly RR, McLeod DG, Srivastava S,
Moul JW (1999). Detection of circulating
prostate specific antigen expressing prostatic
cells in the bone marrow of radical
prostatectomy patients by sensitive
reverse transcriptase polymerase chain
reaction. J Urol 161: 1070-1076.
836. Gardiner RA, Samaratunga ML, Walsh
MD, Seymour GJ, Lavin MF (1992). An
immunohistological demonstration of c-
erbB-2 oncoprotein expression in primary
urothelial bladder cancer. Urol Res 20: 117-
120.
837. Garrett JE, Cartwright PC, Snow BW,
Coffin CM (2000). Cystic testicular lesions
in the pediatric population. J Urol 163: 928-
936.
838. Garufi A, Priolo GD, Coppolino F,
Giammusso B, Materazzo S (1993).
[Computed tomography evaluation of
urothelial carcinomas of the upper urinary
tract]. Radiol Med (Torino) 86: 489-495.
839. Gassel AM, Westphal E, Hansmann
ML, Leimenstoll G, Gassel HJ (1991).
Malignant lymphoma of donor origin after
renal transplantation: a case report. Hum
Pathol 22: 1291-1293.
840. Gatalica Z, Grujic S, Kovatich A,
Petersen RO (1996). Metanephric adenoma:
histology, immunophenotype, cytogenetics,
ultrastructure. Mod Pathol 9: 329-
333.
841. Gattuso P, Carson HJ, Candel A,
Castelli MJ (1995). Adenosquamous carcinoma
of the prostate. Hum Pathol 26: 123-
126.
842. Gaudin PB (1998). Histopathologic
effects of radiation and hormonal therapies
on benign and malignant prostate tissue.
J Urol Pathol 8: 55-67.
843. Gaudin PB, Epstein JI (1994). Adenosis
of the prostate. Histologic features in
transurethral resection specimens. Am J
Surg Pathol 18: 863-870.
844. Gaudin PB, Rosai J, Epstein JI (1998).
Sarcomas and related proliferative lesions
of specialized prostatic stroma: a clinicopathologic
study of 22 cases. Am J Surg
Pathol 22: 148-162.
845. Gaudin PB, Sesterhenn IA, Wojno KJ,
Mostofi FK, Epstein JI (1997). Incidence
and clinical significance of high-grade
prostatic intraepithelial neoplasia in TURP
specimens. Urology 49: 558-563.
846. Gelfand M, Weinberg RW, Castle WM
(1967). Relation between carcinoma of the
bladder and infestation with Schistosoma
haematobium. Lancet 1: 1249-1251.
847. Gelmann EP (2002). Molecular biology
of the androgen receptor. J Clin Oncol 20:
3001-3015.
848. Gels ME, Hoekstra HJ, Sleijfer DT,
Marrink J, de Bruijn HW, Molenaar WM,
Freling NJ, Droste JH, Schraffordt Koops H
(1995). Detection of recurrence in patients
with clinical stage I nonseminomatous testicular
germ cell tumors and consequences
for further follow-up: a singlecenter
10-year experience. J Clin Oncol 13:
1188-1194.
849. Genega EM, Hutchinson B, Reuter VE,
Gaudin PB (2000). Immunophenotype of
high-grade prostatic adenocarcinoma and
urothelial carcinoma. Mod Pathol 13: 1186-
1191.
850. Gentile AT, Moseley HS, Quinn SF,
Franzini D, Pitre TM (1994). Leiomyoma of
the seminal vesicle. J Urol 151: 1027-1029.
851. Gentile JM (1985). Schistosome related
cancers: a possible role for genotoxins.
Environ Mutagen 7: 775-785.
852. Gentile JM (1991). A possible role for
genotoxins in parasite-associated cancers.
Rev Latinoam Genet 1: 239-248.
853. Gentile JM, Brown S, Aardema M,
Clark D, Blankespoor H (1985). Modified
mutagen metabolism in Schistosoma
hematobium-infested organisms. Arch
Environ Health 40: 5-12.
854. Gentile JM, Gentile GJ (1994).
Implications for the involvement of the
immune system in parasite-associated
cancers. Mutat Res 305: 315-320.
855. George DJ, Kaelin WGJr (2003). The
von Hippel-Lindau protein, vascular
endothelial growth factor, and kidney cancer.
N Engl J Med 349: 419-421.
856. Gerald WL, Ladanyi M, de Alava E,
Cuatrecasas M, Kushner BH, LaQuaglia
MP, Rosai J (1998). Clinical, pathologic,
and molecular spectrum of tumors associated
with t(11;22)(p13;q12): desmoplastic
small round-cell tumor and its variants. J
Clin Oncol 16: 3028-3036.
857. Gerald WL, Miller HK, Battifora H,
Miettinen M, Silva EG, Rosai J (1991). Intraabdominal
desmoplastic small round-cell
tumor. Report of 19 cases of a distinctive
type of high-grade polyphenotypic malignancy
affecting young individuals. Am J
Surg Pathol 15: 499-513.
858. Gerald WL, Rosai J, Ladanyi M (1995).
Characterization of the genomic breakpoint
and chimeric transcripts in the EWS-
WT1 gene fusion of desmoplastic small
round cell tumor. Proc Natl Acad Sci USA
92: 1028-1032.
859. Gervasi LA, Mata J, Easley JD,
Wilbanks JH, Seale-Hawkins C, Carlton
CEJr, Scardino PT (1989). Prognostic significance
of lymph nodal metastases in
prostate cancer. J Urol 142: 332-336.
860. Gessler M, Poustka A, Cavenee W,
Neve RL, Orkin SH, Bruns GA (1990).
Homozygous deletion in Wilms tumours of
a zinc-finger gene identified by chromosome
jumping. Nature 343: 774-778.
861. Geurts van Kessel A, Suijkerbuijk RF,
Sinke RJ, Looijenga LH, Oosterhuis JW, de
Jong B (1993). Molecular cytogenetics of
human germ cell tumours: i(12p) and related
chromosomal anomalies. Eur Urol 23:
23-28.
862. Geurts van Kessel A, Wijnhoven H,
Bodmer D, Eleveld M, Kiemeney L, Mulders
P, Weterman M, Ligtenberg M, Smeets D,
Smits A (1999). Renal cell cancer: chromosome
3 translocations as risk factors. J
Natl Cancer Inst 91: 1159-1160.
863. Ghalayini IF, Bani-Hani IH, Almasri NM
(2001). Osteosarcoma of the urinary bladder
occurring simultaneously with prostate
and bowel carcinomas: report of a case
and review of the literature. Arch Pathol
Lab Med 125: 793-795.
864. Ghandur-Mnaymneh L, Gonzalez MS
(1981). Angiosarcoma of the penis with
hepatic angiomas in a patient with low
vinyl chloride exposure. Cancer 47: 1318-
1324.
865. Gheiler EL, Tefilli MV, Tiguert R, de
Oliveira JG, Pontes JE, Wood DPJr (1998).
Management of primary urethral cancer.
Urology 52: 487-493.
866. Ghoneim MA, Ashamallah AK, Awaad
HK, Whitmore WFJr (1985). Randomized
trial of cystectomy with or without preoperative
radiotherapy for carcinoma of the
bilharzial bladder. J Urol 134: 266-268.
867. Gibas Z, Griffin CA, Emanuel BS (1987).
Trisomy 7 and i(5p) in a transitional cell
carcinoma of the ureter. Cancer Genet
Cytogenet 25: 369-370.
868. Gibas Z, Prout GR, Pontes JE, Connolly
JG, Sandberg AA (1986). A possible specific
chromosome change in transitional cell
carcinoma of the bladder. Cancer Genet
Cytogenet 19: 229-238.
869. Gibas Z, Prout GRJr, Connolly JG,
Pontes JE, Sandberg AA (1984).
Nonrandom chromosomal changes in
transitional cell carcinoma of the bladder.
Cancer Res 44: 1257-1264.
870. Gibbons RP, Monte JE, Correa RJJr,
Mason JT (1976). Manifestations of renal
cell carcinoma. Urology 8: 201-206.
871. Gibbs M, Stanford JL, McIndoe RA,
Jarvik GP, Kolb S, Goode EL, Chakrabarti L,
Schuster EF, Buckley VA, Miller EL,
Brandzel S, Li S, Hood L, Ostrander EA
(1999). Evidence for a rare prostate cancer-susceptibility
locus at chromosome
1p36. Am J Hum Genet 64: 776-787.
872. Gibson GE, Ahmed I (2001). Perianal
and genital basal cell carcinoma: A clinicopathologic
review of 51 cases. J Am
Acad Dermatol 45: 68-71.
873. Gierke CL, King BF, Bostwick DG,
Choyke PL, Hattery RR (1994). Large-cell
calcifying Sertoli cell tumor of the testis:
appearance at sonography. AJR Am J
Roentgenol 163: 373-375.
874. Gilbert RF, Ibarra J, Tansey LA,
Shanberg AM (1992). Adenocarcinoma in
a mullerian duct cyst. J Urol 148: 1262-
1264.
875. Gilcrease MZ, Delgado R, Albores-
Saavedra J (1998). Testicular Sertoli cell
tumor with a heterologous sarcomatous
component: immunohistochemical
assessment of Sertoli cell differentiation.
Arch Pathol Lab Med 122: 907-911.
876. Gilcrease MZ, Delgado R, Vuitch F,
Albores-Saavedra J (1998). Clear cell adenocarcinoma
and nephrogenic adenoma
of the urethra and urinary bladder: a
histopathologic and immunohistochemical
comparison. Hum Pathol 29: 1451-1456.
877. Gilcrease MZ, Schmidt L, Zbar B,
Truong L, Rutledge M, Wheeler TM (1995).
Somatic von Hippel-Lindau mutation in
clear cell papillary cystadenoma of the
epididymis. Hum Pathol 26: 1341-1346.
878. Gill HS, Dhillon HK, Woodhouse CR
(1989). Adenocarcinoma of the urinary
bladder. Br J Urol 64: 138-142.
879. Gill IS, Sung GT, Hobart MG, Savage
SJ, Meraney AM, Schweizer DK, Klein EA,
Novick AC (2000). Laparoscopic radical
nephroureterectomy for upper tract transitional
cell carcinoma: the Cleveland
Clinic experience. J Urol 164: 1513-1522.
880. Gillis AJ, Looijenga LH, de Jong B,
Oosterhuis JW (1994). Clonality of combined
testicular germ cell tumors of adults.
Lab Invest 71: 874-878.
881. Gillis AJ, Oosterhuis JW, Schipper
ME, Barten EJ, van Berlo R, van Gurp RJ,
Abraham M, Saunders GF, Looijenga LH
(1994). Origin and biology of a testicular
Wilms’ tumor. Genes Chromosomes
Cancer 11: 126-135.
882. Gillis AJ, Verkerk AJ, Dekker MC, van
Gurp RJ, Oosterhuis JW, Looijenga LH
(1997). Methylation similarities of two CpG
sites within exon 5 of human H19 between
normal tissues and testicular germ cell
tumours of adolescents and adults, without
correlation with allelic and total level
of expression. Br J Cancer 76: 725-733.
883. Gilman PA (1983). The epidemiology of
human teratomas. In: The Human
Teratomas: Experimental and Clinical
Biology, I Damjavov, BB Knowles, D Solter,
eds. Humana Press: Clifton, NJ, pp. 81-104.
884. Giovannucci E, Stampfer MJ, Krithivas
K, Brown M, Dahl D, Brufsky A, Talcott J,
Hennekens CH, Kantoff PW (1997). The CAG
repeat within the androgen receptor gene
and its relationship to prostate cancer. Proc
Natl Acad Sci USA 94: 3320-3323.
885. Givler RL (1971). Involvement of the
bladder in leukemia and lymphoma. J Urol
105: 667-670.
886. Giwercman A, Andrews PW,
Jorgensen N, Muller J, Graem N,
Skakkebaek NE (1993). Immunohistochemical
expression of embryonal marker
TRA-1-60 in carcinoma in situ and germ
cell tumors of the testis. Cancer 72: 1308-
1314.
887. Giwercman A, Bruun E, Frimodt-Moller
C, Skakkebaek NE (1989). Prevalence of carcinoma
in situ and other histopathological
abnormalities in testes of men with a history
of cryptorchidism. J Urol 142: 998-1001.
888. Giwercman A, Cantell L, Marks A (1991).
Placental-like alkaline phosphatase as a
marker of carcinoma-in-situ of the testis.
Comparison with monoclonal antibodies
M2A and 43-9F. APMIS 99: 586-594.
889. Giwercman A, Lindenberg S, Kimber
SJ, Andersson T, Muller J, Skakkebaek NE
(1990). Monoclonal antibody 43-9F as a sensitive
immunohistochemical marker of carcinoma
in situ of human testis. Cancer 65:
1135-1142.
890. Giwercman A, Marks A, Bailey D,
Baumal R, Skakkebaek NE (1988). A monoclonal
antibody as a marker for carcinoma
in situ germ cells of the human adult testis.
APMIS 96: 667-670.
891. Giwercman A, Muller J, Skakkebaek NE
(1991). Prevalence of carcinoma in situ and
other histopathological abnormalities in
testes from 399 men who died suddenly and
unexpectedly. J Urol 145: 77-80.
892. Giwercman A, von der Maase H,
Skakkebaek NE (1993). Epidemiological and
clinical aspects of carcinoma in situ of the
testis. Eur Urol 23: 104-110.
893. Glavac D, Neumann HP, Wittke C,
Jaenig H, Masek O, Streicher T, Pausch F,
Engelhardt D, Plate KH, Hofler H, Chen F,
Zbar B, Brauch H (1996). Mutations in the
VHL tumor suppressor gene and associated
lesions in families with von Hippel-Lindau
disease from central Europe. Hum Genet 98:
271-280.
894. Gleason DF (1966). Classification of prostatic
carcinomas. Cancer Chemother Rep
50: 125-128.
895. Gleason DF (1977). Histologic grading
and clinical staging of prostatic carcinoma.
In: Urologic Pathology: The Prostate, M
Tannenbaum, ed. Lea and Feibiger:
Philadelphia.
896. Glover SD, Buck AC (1982). Renal
medullary fibroma: a case report. J Urol 127:
758-760.
897. Gnarra JR, Tory K, Weng Y, Schmidt L,
Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM,
Lubensky I, Duan DR, Florence CD, Pozzatti
RO, Walther MM, Bander NH, Grossman
HB, Brauch H, Pomer S, Brooks JD, Isaacs
WB, Lerman MI, Zbar B, Linehan WM
(1994). Mutations of the VHL tumour suppressor
gene in renal carcinoma. Nat Genet
7: 85-90.
898. Goddard JC, Sutton CD, Jones JL,
O’Byrne KJ, Kockelbergh RC (2002).
Reduced thrombospondin-1 at presentation
predicts disease progression in superficial
bladder cancer. Eur Urol 42: 464-468.
899. Goebbels R, Amberger L, Wernert N,
Dhom G (1985). Urothelial carcinoma of the
prostate. Appl Pathol 3: 242-254.
References 319